Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoRecormon via Reco-Pen in Pre-Dialysis Chronic Renal Anemia
NCT02569515Phase 4Completed
- Sponsor
- Roche
- Start
- Oct 2004
- Primary completion
- Jul 2006
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 4 trial of epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Started Oct 2004; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02569515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02569515.